1 Findings from a phase 2 study (NCT05548296) presented during the 2024 ESMO Congress demonstrated that response-evaluable patients with endometrial carcinoma who were positively ... experienced ...

RNF183, a member of the E3 ubiquitin ligase, has been shown to involve in carcinogenesis and proposed as one of the biomarkers in Uterine Corpus Endometrial Carcinoma (UCEC ... mostly higher in ...

Almost 15% of outpatient cases and 25% of gyne-surgery cases present with AUB [1]. It is therefore important to understand ... bleeding but it did not increase the diagnosis of endometrial carcinoma.

Abemaciclib is under development for the treatment of Kaposi sarcoma, metastatic gastroesophageal junction adenocarcinoma, neuroblastoma, platinum-resistant ovarian cancer, adenocarcinoma of the ...

Case 1. A.G. (M.G.H. 572590), a 61-year-old woman, 4 years before admission to this study had a panhysterectomy and later x-ray therapy for adenocarcinoma of the endometrium. In October ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium ... of any size with adjacent spread (1/3 lower urethra, 1/3 lower vagina, anus ...

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

known as advanced renal cell carcinoma, and certain types of advanced endometrial carcinoma — a type of uterine cancer. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar) ...

In the LEAP-015 trial, Keytruda and Lenvima plus chemo did not meet the primary end point of overall survival in HER2– gastroesophageal adenocarcinoma. Treatment with the anti-PD-1 therapy Keytruda ..

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...